CDKN2A and lung cancer: Low levels of p53 mutation, abnormal p16INK4A methylation, loss of MLH1 expression and, consequently, an increase in microsatellite instability can be observed in human lung cancer cells associated with Cr(VI) exposure [33, 34, 42].